ReviewFrontiers in pharmacology2021

Risk of Malignancy and Tuberculosis of Biological and Targeted Drug in Patients With Spondyloarthritis: Systematic Review and Meta-analysis of Randomized Controlled Trials.

Siliang Man et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.